Effects of nicardipine on coronary, vertebral and renal arterial flows in patients with essential hypertension

被引:10
|
作者
Suzuki, S [1 ]
Ohtsuka, S [1 ]
Ishikawa, K [1 ]
Yamaguchi, I [1 ]
机构
[1] Univ Tsukuba, Inst Clin Med, Dept Internal Med, Div Cardiovasc, Tsukuba, Ibaraki, Japan
关键词
hypertension; nicardipine; vertebral flow; renal flow; coronary flow;
D O I
10.1291/hypres.26.193
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
We examined the acute effects of a calcium antagonist, nicardipine, on hemodynamics and blood flow in the left anterior descending coronary (LAD), vertebral and renal arteries of essential hypertensive patients who had complained of chest pain and undergone cardiac catheterization. The blood flow velocities of the LAD, vertebral and renal arteries were measured using a Doppler guidewire and the arterial luminal diameters were measured from the arteriograms. The arterial blood flow was calculated by multiplying the blood flow velocity by the obtained vessel diameter. Coronary flow reserve was evaluated by injecting papaverine into the left coronary artery. After the baseline data had been obtained, intravenous infusion of nicardipine was started and the same hemodynamic, blood flow velocity and arterial diameter measurements were repeated. Blood pressure was decreased and cardiac output was increased by nicardipine infusion. There was a correlation between the decrease in systolic blood pressure and the increase in cardiac output (r= 0.71). The blood flow velocity in the LAD, vertebral and renal arteries tended to increase and there was an increase in the arterial luminal diameter. An increase in blood flow and a lowering of vascular resistance were observed for each artery (p<0.05). During nicardipine infusion, the diastolic blood flow in the LAD artery was improved (p<0.05); however, the maximal blood flow in the LAD artery induced by papaverine infusion remained unchanged. Therefore, there is evidence that coronary, vertebral and renal blood flows are improved by nicardipine infusion despite the acute blood pressure reduction.
引用
收藏
页码:193 / 199
页数:7
相关论文
共 50 条
  • [21] NICARDIPINE - VASCULAR PARIETAL EFFECTS AND DEVELOPMENT OF GENETIC ARTERIAL-HYPERTENSION
    MAURY, M
    FRESLON, JL
    RICHER, C
    BUCHER, B
    STOCLET, JC
    GIUDICELLI, JF
    THERAPIE, 1984, 39 (01): : 73 - 74
  • [22] ACUTE HEMODYNAMIC-EFFECTS OF INTRAVENOUS NICARDIPINE IN ESSENTIAL-HYPERTENSION
    MAUREL, C
    CHAIGNON, M
    GUEDON, J
    CLINICAL AND EXPERIMENTAL HYPERTENSION PART A-THEORY AND PRACTICE, 1987, 9 (11) : 1917 - 1917
  • [23] LONG-TERM EFFECTS OF NICARDIPINE IN THE TREATMENT OF ESSENTIAL-HYPERTENSION
    MURRAY, TS
    LANGAN, J
    COXHEAD, PF
    LEVINSON, N
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 22 : S249 - S257
  • [24] Effects of amlodipine and bisoprolol on carotid and vertebral blood flow in patients with arterial hypertension
    Golovanova, E. D.
    Silaeva, N. N.
    Kovalev, D. Y.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2009, 5 (05) : 29 - 34
  • [25] ACUTE EFFECTS OF INTRAVENOUS NICARDIPINE IN THE ELDERLY SUBJECT WITH ARTERIAL-HYPERTENSION
    ESCANDE, M
    DAVID, D
    DIADEMA, B
    THERAPIE, 1989, 44 (03): : 161 - 165
  • [26] NICARDIPINE - VASCULAR PARIETAL EFFECTS AND DEVELOPMENT OF HEREDITARY ARTERIAL-HYPERTENSION
    MAURY, M
    FRESLON, JL
    RICHER, C
    BUCHER, B
    STOCLET, JC
    GIUDICELLI, JF
    JOURNAL DE PHARMACOLOGIE, 1984, 15 (01) : 98 - 99
  • [27] The Management of Acute Hypertension in Patients With Renal Dysfunction: Labetalol or Nicardipine?
    Varon, Joseph
    Soto-Ruiz, Karina M.
    Baumann, Brigitte M.
    Borczuk, Pierre
    Cannon, Chad M.
    Chandra, Abhinav
    Cline, David Martin
    Diercks, Deborah B.
    Hiestand, Brian
    Hsu, Amy
    Jois-Bilowich, Preeti
    Kaminski, Brian
    Levy, Phillip
    Nowak, Richard M.
    Schrock, Jon W.
    Peacock, W. Frank
    POSTGRADUATE MEDICINE, 2014, 126 (04) : 124 - 130
  • [28] Renal and Vascular Protective Effects of Telmisartan in Patients with Essential Hypertension
    Satoshi Morimoto
    Yutaka Yano
    Kei Maki
    Katsunori Sawada
    Hypertension Research, 2006, 29 : 567 - 572
  • [29] Renal and vascular protective effects of telmisartan in patients with essential hypertension
    Morimoto, Satoshi
    Yano, Yutaka
    Maki, Kei
    Sawada, Katsunori
    HYPERTENSION RESEARCH, 2006, 29 (08) : 567 - 572
  • [30] Renal and vascular protective effects of cilnidipine in patients with essential hypertension
    Morimoto, Satoshi
    Yano, Yutaka
    Maki, Kei
    Iwasaka, Toshiji
    JOURNAL OF HYPERTENSION, 2007, 25 (10) : 2178 - 2183